Weinstein, P.L. et al. Unusual Cardiac Reaction to Chemotherapy Following Mediastinal Irradiation in Patients with Hodgkin's Disease. Am. J. Med. 60:152. 1976.
Cook, J.; Friedman, M.; Weinstein, P.L. Iron Supplements: Which Patient Really Needs Iron? Patient Care. 10:72, 1976.
Baranetsky, N.G.; Weinstein, P.L. Partial Thromboplastin Time for Screening. Ann Int. Med. 9l:498. 1979.
Arlin, Zalmen A.; Ahmed, Tauseef; Mittleman, Abraham; Feldman, Eric; Mehta, Rakesh; Weinstein, Paul L.; Rieber, Egmond; Sullivan, Phyllis; and Baskind, Paul. A New Regimen of Amsacrine With High Dose Cytarabine Is Safe and Effective Therapy for Acute Leukemia. Journal of Clinical Oncology. Vol. 5, No. 3. March, 1987. pp 371 375.
Shattuck-Eidens D, Oliphant A, McClure M, McBride C, Gupte J, Rubano T, Pruss D, Tavtigian SV, Teng D H-F, Adey N, Staebell M, Gumpper K, Lundstrom R, Hulick M, Kelly M, Holmen J, Lingenfelter B, Manley S, Fujimura F, Luce M, Ward B, Cannon-Albright L, Steele L, Offit K, Gilewski T, Norton L, Brown K, Schulz C, Hampel H, Schluger A, Giulotto E, Zoli W, Ravaioli A, Nevanlinna H, Pyrhonen S, Rowley P, Loader S, Osborne MP, Daly M, Tepler I, Weinstein PL, Scalia JL, Michaelson R, Scott RJ, Radice P, Pierotti MA, Garber JE, Isaacs C, Peshkin B, Lippman ME, Dosik MH, Caligo MA, Greenstein RM, Pilarski R, Weber B, Burgemeister R, Frank TS, Skolnick MH, Thomas A. BRCA1 sequence analysis in women at high risk for susceptibility mutations: risk factor analysis and implications for genetic testing. JAMA. 278:1242-1250. 1997.
Salvatore A. Del Prete, M.D., Scott P. Ryan, Judith S. Jacobson, DR.PH, Robert B. Erichson, M.D., Paul L. Weinstein, M.D., and Victor R. Grann, M.D. Safety and Costs of Treating Neutropenic Fever in an Outpatient Setting. Connecticut Medicine. Volume 63, No. 12; 713:717. December 1999.
K.M. Steve Lo, M. Beer, A. Conkling, P. Kosonen, V.R. Grann, R.B. Erichson, P.L. Weinstein, S.A. Del Prete, N.S. Cohen, D. Xistris, M.H. Bar. Paclitaxel (TXL) + Cyclophosphamide (CTX) + G-CSF and Etoposide (VP) + CTX + G-CSF are Similar in Their Ability to Mobilize Peripheral Blood Progenitor Cell (PBCS) in Patients with Breast Cancer Undergoing High Dose Chemotherapy (HDC). Blood. 1995. Vol. 86, NO 10: Suppl 1: 986a [Abstract 3934].
S. Ryan, S. DelPrete, P. Weinstein, R. Erichson, M. Bar, S. Lo, N. Cohen, I. Tepler: Low-Dose Vincristine-Associated Bilateral Vocal Cord Paralysis. Connecticut Medicine. October 1999. Vol. 63, NO. 10, pp. 583-584.
Donate
Search